Submission Details
| 510(k) Number | K963054 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 1996 |
| Decision Date | May 05, 1997 |
| Days to Decision | 272 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K963054 is an FDA 510(k) clearance for the IMMUNOWELL MYCOPLASMA PNEUMONIA ANTIBODY (IGM) TEST (3130), a Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp. (Class I — General Controls, product code LJZ), submitted by Genbio (San Diego, US). The FDA issued a Cleared decision on May 5, 1997, 272 days after receiving the submission on August 6, 1996. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3375.
| 510(k) Number | K963054 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 1996 |
| Decision Date | May 05, 1997 |
| Days to Decision | 272 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LJZ — Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp. |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3375 |